logo hivtri hiv training & resource initiativehomeabout hivtritrainerstestimonialscontact uslinksfunderssitemap
www.hivtri.commadrid spain
 
eacs treatment guidelines
UPCOMING PROGRAMMES
HIVTRI 2009 Diary
 
COMPLETED PROJECTS
Skopje, October 2008
Istanbul, September 2008
Krakow, June 2008
Warsaw, April 2008
Antwerp, April 2008
Pune, March 2008
Bath, August 2007
Oxford, July 2007
Belgrade, May 2007
Turin, May 2007
Madrid, April 2006

Managing HIV and Co-infection

27–28 April 2006, San Lorenzo de El Escorial, Madrid, Spain

 

pic: sanjay bhagani Sanjay Bhagani

Dr. Bhagani is a Consultant Physician in Infectious Diseases and HIV Medicine at the Royal Free Hospital. He has a special interest in HIV/hepatitis co-infections and runs a large multidisciplinary HIV/ hepatitis co-infection service at the Royal Free Hospital. He has been involved in a study of viral relationships and risk-factors for the recent epidemic of acute HCV in HIV-positive gay men in the UK.

TOP OF PAGE

pic: marta boffito Marta Boffito

Dr Boffito graduated from the University of Turin, Turin, Italy in Medicine in 1996. She trained in general medicine and infectious diseases at the University of Turin and at the University of California at San Francisco, California, USA (with the Department of HIV at the General Hospital) and became a specialist in Infectious Diseases/HIV in 2001. Her HIV-related research was focused on antiretroviral therapies and AIDS-related lymphoma. She obtained her PhD in 2004 at the University of Liverpool, Liverpool, UK (Department of Pharmacology and Therapeutics, Prof. DJ Back) with a thesis entitled “Clinical Pharmacology of Human Immunodeficiency Virus-1 Protease Inhibitors” which covered the pharmacokinetics and pharmacodynamics of antiretroviral therapy for HIV. Currently, she is the Associate Director of the Pharmacokinetic Research Unit at Chelsea and Westminster Hospital, London, where, in addition to her clinical duties, she is heavily involved in numerous clinical studies.

TOP OF PAGE

pic: martin fisherMartin Fisher

Martin Fisher is a Consultant in HIV at Brighton and Sussex University Hospitals NHS Trust. He is responsible for the outpatient and inpatient management of a large cohort of HIV infected individuals, leads an active research team, and has established an HIV/hepatitis co-infection clinic with local hepatologists. He is an executive committee member of the British HIV Association, a member of the HIV Special Interest Group of the British Association for Sexual Health and HIV, and is the Convenor of the national Diploma in HIV Medicine. His main clinical and research interests are in antiretroviral therapy, primary HIV infection, HIV and hepatitis co-infection, and the interplay between HIV and other sexually transmitted infections.

TOP OF PAGE

pic: anna-maria gerettiAnna-Maria Geretti

Dr Anna-Maria Geretti is a Consultant Medical Virologist and Honorary Senior Lecturer at the Royal Free Hospital in London, where she heads the Retrovirology laboratory and also works as a physician with a specialist interest in HIV medicine, viral hepatitis and genital herpes. She trained in Italy, the Netherlands and the UK, and holds an MD in Medicine and a PhD in the virology and immunology of HIV infection. She is an executive member of the British HIV Association (BHIVA) Executive Committee and contributes to the production of the BHIVA Treatment Guidelines. She is an advisor to the British National Formulary and editor of the Journal of Antimicrobial Chemotherapy and the Journal of HIV Therapy.

TOP OF PAGE

pic: santiago morenoSantiago Moreno

Santiago Moreno, MD is the Chief of the Department of Infectious Diseases at the Hospital Ramón y Cajal, in Madrid, a large referral hospital that treats approximately 1,800 HIV-infected patients (more than 1,400 are undergoing antiretroviral therapy). Dr. Moreno graduated in Medicine at the Medical School of the University of Murcia, Spain, in 1982. He completed his fellowship in Infectious Diseases at the Department of Infectious Diseases, Hospital Ramón y Cajal, Madrid, in 1987. In 1990, he had a training period at the AIDS Clinical Research Centre at UCLA. Dr. Moreno has been involved with HIV-infected patients since the very beginning of the AIDS epidemic in Spain. He has collaborated with the Spanish Ministry of Health in setting recommendations related to clinical aspects of HIV infection/AIDS, regarding antiretroviral therapy, resistance testing and opportunistic infections. Dr. Moreno has developed intensive scientific activity. He has been a speaker at multiple national and international meetings, symposia and conferences and is the author of more than 100 peer-reviewed national and international papers. The main areas of HIV infection on which Dr. Moreno has focused are different aspects of antiretroviral therapy and HIV-related tuberculosis. His recent publications include reports in Annals of Internal Medicine, New England Journal of Medicine, AIDS, and Archives of Internal Medicine.

TOP OF PAGE

pic: mike youleMike Youle

After qualifying at Sheffield Medical School, UK, Dr Mike Youle helped found the world-renowned Kobler Clinic in London in 1986 as Clinical Trials Co-ordinator. Other than a 1-year stint working as a Consultant for the World Health Organization’s Global Programme on AIDS and the National Programme on AIDS in Kampala, Dr Youle has devoted most of his career to the clinical care of HIV patients. Since 1996 he has been the Director of HIV Clinical Research at London’s Royal Free Hospital as well as an Honorary Senior Lecturer in Public Health at its associated medical school. His numerous professional activities currently include a visiting professorship for Belgrade University and board/committee memberships for organizations such as the International Association of Physicians in AIDS Care, the British HIV Association and the MANON Therapeutic Vaccine Programme. Dr Youle also serves as a trustee of the Red Hot AIDS Charitable Trust and the National AIDS Manual, as well as medical advisor to the Elton John AIDS Foundation.

TOP OF PAGE

 

horizontal rule

logo: e.a.c.s.

 

Funding is provided by non-restricted educational grants from Roche and Gilead.

logo: roche  logo: gilead

Please contact us if you find anything on this website that is incorrect or could be improved upon at .